DGA GROUP GOVERNMENT RELATIONS LLC

Lobbying for VIIV HEALTHCARE · Biopharmaceutical company focused on HIV prevention and treatment

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $10,000.00 income · posted Apr 16, 2026

Lobbying activity 1

Trade (domestic/foreign)

Defense of US pharmaceutical intellectual property rights and incentives

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.